Publication Name	World Journal of Transplantation
Manuscript ID	79270
Country	United States

Received	2022-09-09 02:38
Peer-Review Started	2022-09-09 02:40
To Make the First Decision
Return for Revision	2022-10-21 02:38
Revised	2022-11-03 02:37
Second Decision	2022-11-14 03:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-11-23 03:12
Articles in Press	2022-11-23 03:12
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-12-02 21:40
Typeset the Manuscript	2022-12-14 07:11
Publish the Manuscript Online	2022-12-16 08:56

ISSN	2220-3230 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Minireviews
Article Title	Review of heart transplantation from hepatitis C-positive donors
Manuscript Source	Unsolicited Manuscript
All Author List	Palak Patel, Nirav Patel, Fahad Ahmed and Jason Gluck
Funding Agency and Grant Number
Corresponding Author	Jason Gluck, FACC, Attending Doctor, Chief Physician, Advance Heart Failure, Hartford Hospital, 85 Seymour Street, Hartford, CT 06102, USA, Hartford, CT 06102, United States. jason.gluck@hhchealth.org
Key Words	Heart transplant; Hepatitis C positive donors; Direct-acting antiretroviral; Coronary allograft vasculopathy; Allograft rejection
Core Tip	Given favorable preliminary data and ongoing opioid epidemic, the utilization of hepatitis C virus (HCV)-positive hearts is on the rise aiding to close the gap between heart transplantation candidates and donors. Additionally, with future studies evaluating long-term outcomes and standardization of direct-active antiviral therapy, more transplant centers will accept HCV-positive organs.
Publish Date	2022-12-16 08:56
Citation	Patel P, Patel N, Ahmed F, Gluck J. Review of heart transplantation from hepatitis C-positive donors. World J Transplant 2022; 12(12): 394-404
URL	https://www.wjgnet.com/2220-3230/full/v12/i12/394.htm
DOI	https://dx.doi.org/10.5500/wjt.v12.i12.394

Full Article (PDF)	WJT-12-394.pdf
Full Article (Word)	WJT-12-394.docx
Manuscript File	79270-Review-FilipodiaCL.docx
Answering Reviewers	79270-Answering reviewers.pdf
Audio Core Tip	79270-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	79270-Conflict-of-interest statement.pdf
Copyright License Agreement	79270-Copyright license agreement.pdf
Peer-review Report	79270-Peer-review(s).pdf
Scientific Misconduct Check	79270-Bing-Liu JH-2.jpg
Scientific Misconduct Check	79270-CrossCheck.jpg
Scientific Editor Work List	79270-Scientific editor work list.pdf